Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 1;16(3):e55352.
doi: 10.7759/cureus.55352. eCollection 2024 Mar.

Painless Thyroiditis by Withania somnifera (Ashwagandha)

Affiliations
Case Reports

Painless Thyroiditis by Withania somnifera (Ashwagandha)

Maho Hayashi et al. Cureus. .

Abstract

The Withania somnifera, also called Ashwagandha, is available everywhere in the world. We present a rare case of thyrotoxicosis following Ashwagandha administration, specifically painless thyroiditis (PT) in this report. The patient was a 47-year-old previously healthy Japanese man, who started taking Ashwagandha two months before his first visit to our hospital. He visited our hospital for typical thyrotoxicosis symptoms like a sense of fatigue, fever at night, and weight loss followed by diarrhea and headache. Blood tests disclosed thyrotoxicosis. Thyroid ultrasonography showed internal echo heterogeneity and no increase in blood flow. Thyroid scintigraphy revealed a deficiency in thyroid uptake. Based on these findings, he was diagnosed as PT. After stopping the administration of Ashwagandha, both his symptoms and serum thyroid markers were improved. This report may spark important debate about whether ashwagandha is safe among healthy people, especially in thyroid toxicity.

Keywords: ashwagandha (withania somnifera); drug-induced thyrotoxicosis; painless thyroiditis; subacute lymphocytic thyroiditis; thyrotoxicosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. The result of thyroid ultrasonography.
Thyroid ultrasonography (US) showing slightly enlargement of thyroid gland and internal heterogeneity (A: right lobe, B: left lobe). Color flow Doppler enhancement of the US images showing no increase in blood flow (C: right lobe, D: left lobe).
Figure 2
Figure 2. The result of thyroid 99mTcO4 scintigraphy.
Thyroid 99mTcO4 scintigraphy showing almost no uptake in thyroid gland (arrowheads).
Figure 3
Figure 3. Schema of clinical course in our case.
The initial visit to our hospital was defined as day 0. Symptoms were developed after taking Ashwagandha and recovered after stopping it. The levels of thyroid marker showing in this schema including free triiodothyronine (FT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH). After stopping administration of Ashwagandha, FT3 and FT4 were decreased within reference range.

References

    1. Effects of Withania somnifera (ashwagandha) on stress and the stress- related neuropsychiatric disorders anxiety, depression, and insomnia. Speers AB, Cabey KA, Soumyanath A, Wright KM. Curr Neuropharmacol. 2021;19:1468–1495. - PMC - PubMed
    1. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Dar NJ, Hamid A, Ahmad M. Cell Mol Life Sci. 2015;72:4445–4460. - PMC - PubMed
    1. Shahid MA, Ashraf MA, Sharma S. Treasure Island, FL: StatPearls Publishing; 2024. Physiology, Thyroid Hormone. - PubMed
    1. Thyrotoxicosis: diagnosis and management. Sharma A, Stan MN. Mayo Clin Proc. 2019;94:1048–1064. - PubMed
    1. Thyroiditis: Differential diagnosis and management. Slatosky J, Shipton B, Wahba H. https://www.aafp.org/pubs/afp/issues/2000/0215/p1047.html. Am Fam Physician. 2000;61:1047–1052. - PubMed

Publication types

LinkOut - more resources